Loading ACAD charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading ACAD comparable companies…
| ACADAcadia Pharmaceuticals Inc.(opens in a new tab) | $3.56B | $1.14B | +11.8% | 91.1% | 7.6% | 3.13× | 9.2× |
|---|---|---|---|---|---|---|---|
| PTCTPTC Therapeutics, Inc.(opens in a new tab) | $5.00B | $1.16B | −35.1% | 96.0% | 12.8% | 4.33× | — |
| PBHPrestige Consumer Healthcare Inc.(opens in a new tab) | $2.34B | $1.10B | −1.4% | 53.5% | 26.3% | 2.12× | 13.8× |
| LKFTLakefront Biotherapeutics NV(opens in a new tab) | $2.13B | $1.26B | +321.6% | 97.3% | 26.5% | 1.69× | 5.9× |
| MDGLMadrigal Pharmaceuticals, Inc.(opens in a new tab) | $12.54B | $1.28B | +149.0% | — | −25.1% | 9.77× | — |
| Medianpeers, excl. ACAD | $3.67B | $1.21B | +73.8% | 96.0% | 19.5% | 3.22× | 9.8× |